ReSound OMNIA miniRIE vs Signia Pure C&G IX

The ReSound OMNIA miniRIE is a premium behind-the-ear prescription hearing aid released in 2022, priced at $4,764. In our lab testing, it earned an A grade with a SoundScore of 4.0/5, ranking #24 of 36 devices in the Prescription Hearing Aid category. This device demonstrates solid performance in speech clarity for quiet environments, scoring 3.7/5—0.34 points above the category average. However, speech understanding in noisy situations is a notable weakness, with a score of just 1.0/5, falling 0.96 points below the category average. This contrast suggests the OMNIA miniRIE performs best for users who primarily need support in calmer listening environments rather than challenging acoustic situations like busy restaurants or crowded gatherings. Feedback handling is strong at 4.1/5 in absolute terms, though it sits 0.61 points below the category average of 4.71/5. Own-voice comfort scores 2.9/5, slightly above average but mixed in absolute terms. Music streaming performance is similarly positioned at 2.7/5—essentially at the category average. The OMNIA miniRIE features rechargeable batteries, iPhone and Android streaming capability, and hands-free functionality. It has received the Expert's Choice Award in both 2023 and 2024. At this premium price point, buyers should be aware that several same-price competitors like the Phonak Sphere Infinio and Oticon Intent offer higher overall scores in our testing. This device may suit users prioritizing quiet-environment speech clarity and brand-specific features over maximum performance in noise.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.